2013 US Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

December 2012 | 43 pages | ID: 2AB387D5C91EN
Venture Planning Group

Abstracts

This new 43-page report from Venture Planning Group provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contains 43 pages and 9 tables

Contents

BUSINESS ENVIRONMENT

1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. Laboratory Regulations

MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
  c. Blood Banks
    1) Community and Regional Centers
    2) Plasma Fractionation Centers
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Point of Care Testing
  c. Other Decentralized Testing Locations

MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES

LIST OF TABLE

Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
List of Table (Continued)
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers